Cardiovascular effects of intravenous anesthetics

International Anesthesiology Clinics

Volumn 40, Issue 1, 2002, Pages 15-33

  Patel, Samir ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTRAVENOUS ANESTHETIC AGENT;

ANESTHESIA COMPLICATION; CARDIOVASCULAR EFFECT; DRUG EFFECT; HUMAN; INTRAVENOUS ANESTHESIA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT;

EID: 0036144819     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200201000-00004     Document Type: Review

References (131)

1. The effect of thiopental on peripheral venous tone
2. Effects of thiopental on tension development, action potential, and exchange of calcium and potassium in rabbit ventricular myocardium
3. Inotropic effects of propofol, thiopental, midazolam, etomidate and ketamine on isolated human atrial muscle
4. Role of the endocardial endothelium in the negative inotropic effects of thiopental
5. Brain nitric oxide synthase activity is decreased by intravenous anesthetics
6. Mechanism of the negative inotropic effect of thiopental in isolated ferret ventricular myocardium
7. 2+ release from sarcoplasmic reticulum in intact myocardium
8. Peripheral vascular effects of thiopental and propofol in humans with artificial hearts
9. The effects of short-acting barbiturates on arterial pressure, preganglionic sympathetic activity and barostatic reflexes
10. Haemodynamics, myocardial function, oxygen requirements, and supply of the human heart after administration of etomidate
11. Cardiovascular and ventilatory effects of intravenous anesthetics
12. Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients: A comparison with etomidate
13. The cardiorespiratory effects of ICI 35 868 in patients with valvular heart disease
14. Acute cardiovascular changes following disoprofol: Effects in heavily sedated patients with coronary artery disease
15. A comparison of the haemodynamic effects of propofol (Diprivan) and thiopentone in patients with coronary artery disease
16. Haemodynamic changes during anaesthesia induced and maintained with propofol
17. Effect of propofol anesthesia on baroreflex activity in humans
18. Cardiovascular responses during sedation after coronary revascularization: Incidence of myocardial ischemia and hemodynamic episodes with propofol versus midazolam
19. Negative inotropic effects of propofol as evaluated by the regional preload recruitable stroke work relationship in chronically instrumented dogs
20. Does propofol really preserve baroreflex function in humans?
21. 2+ channel blocker
22. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate
23. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia
24. Hemodynamic effects of infusions of the emulsion formulation of propofol during nitrous oxide anesthesia in humans
25. Propofol and autonomic reflex function in humans
26. Problems with ketamine in adults
27. A study of a 1-aryl-cyclo-hexyl amine for anesthesia
28. Sernyl (CI-395) in clinical anesthesia
29. Cyclohexamine (CI-400): A new intravenous agent
30. Dissociative anesthesia: Further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581
31. Ketamine: Its pharmacology and therapeutic uses
32. Dissociative anesthesia
33. On the cerebral accumulation of ketamine and the relationship between metabolism of the drug and its pharmacological effects
34. Ketamine-lorazepam: Attenuation of the psychic sequelae of ketamine by lorazepam
35. A double-blind study of the effective anti-hallucinatory doses of diazepam prior to ketamine anesthesia
36. The action of S-(+)-ketamine on serum catecholamine and cortisol: A comparison with ketamine racemate
37. Coronary blood flow and myocardial oxygen consumption in patients during induction of anesthesia with droperidol/fentanyl or ketamine
38. Clinical pharmacology and current uses of ketamine
39. A comparison of some cardiorespiratory effects of althesin and ketamine when used for induction of anaesthesia in patients with cardiac disease
40. Cardiovascular and respiratory function with CI-581
41. Clinical pharmacology and current uses of ketamine
42. A physiologic analysis of cardiopulmonary responses to ketamine anesthesia in noncardiac patients
43. Comparison of morphine and ketamine anesthetic techniques for coronary surgery: A randomized study
44. The cardiovascular effects of ketamine used for induction of anaesthesia in patients with valvular heart disease
45. Hemodynamic effects of ketamine in children with congenital heart disease
46. Ketamine for cardiac catheterization: An evaluation of its use in children
47. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance
48. An experimental study of the mechanism of action of ketamine on the central nervous system
49. Cardiovascular effects of centrally administered ketamine in goats
50. Diazepam for prevention of the rise in plasma catecholamines caused by ketamine
51. The effect of ketamine on catecholamine metabolism in the isolated perfused rat heart
52. Electrophysiologic mechanisms responsible for inotropic responses to ketamine in guinea pig and rat myocardium
53. Interactions of ketamine with vasoactive amines at normothermia and hypothermia in the isolated rabbit heart
54. Inhibition of neuronal and extraneuronal uptake of noradrenaline by ketamine in the isolated perfused rat heart
55. Pharmacology of intravenous anesthetic induction drugs
56. The cardiovascular response to ketamine: The effects of clonidine and lignocaine
57. Diazepam-ketamine anaesthesia for open heart surgery: A "micro-mini" drip administration technique
58. The effects of ketamine on cardiovascular dynamics during halothane and enflurane anesthesia
59. Haemodynamic stability with midazolamketamine-sufentanil analgesia in cardiac surgical patients
60. Etomidate, R-(+)-Ethyl-1-(alphamethyl-benzyl)imidazole-5-carboxylate (R 16659): A potent, short-acting and relatively atoxic intravenous hypnotic agent in rats
61. Etomidate, a new intravenous hypnotic
62. Etomidate
63. GABA: Mimetic action of etomidate
64. Direct effects of etomidate and ketamine on regional myocardial contractility in dogs
65. Comparison of a new formulation of etomidate with thiopental: Side effects and awakening times
66. Etomidate infusion in thoracic anaesthesia
67. Pharmacology of etomidate
68. Etomidate
69. Pharmacokinetics of etomidate, a new intravenous anesthetic
70. Pharmacokinetics of etomidate associated with prolonged i.v. infusion
71. The plasma protein binding and distribution of etomidate in dog, rat and human blood
72. Cardiorespiratory changes following induction of anaesthesia with etomidate in patients with cardiac disease
73. Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease
74. Effect of etomidate on the cardiovascular system
75. Cardiovascular effects of etomidate used for induction and in combination with fentanyl-pancuronium for maintenance of anaesthesia in patients with valvular heart disease
76. Propofol/fentanyl versus etomidate/fentanyl for the induction of anesthesia in patients with aortic insufficiency and coronary artery disease
77. Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients: A comparison with etomidate
78. Prolongation of the QT-interval during induction of anesthesia in patients with coronary artery disease
79. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate
80. Etomidate versus thiopental for induction of anesthesia
81. General anesthesia during percutaneous transluminary coronary angioplasty for acute myocardial infarction: Results of a randomized controlled clinical trial
82. Influence of sedation on mortality in critically ill multiple trauma patients
83. Etomidate and adrenocortical function
84. Effect of a single bolus dose of etomidate upon eight major corticosteroid hormones and plasma ACTH
85. Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells
86. Effects of etomidate on hormonal responses to surgical stress
87. Inhibition of adrenal steroidogenesis by the anesthetic etomidate
88. Etomidate inhibits adrenocortical function in surgical patients
89. Narcotic "anesthesia" in the eighties
90. Does opioid "anesthesia" exist?
91. Fentanyl and sufentanil anesthesia revisited: How much is enough?
92. Intraoperative awareness during high-dose fentanyl-oxygen anesthesia
93. Awareness and recall with high-dose fentanyl oxygen anesthesia
94. Hemodynamic changes prior to and after sternotomy in patients anesthetized with high-dose fentanyl
95. Blood pressure response and plasma fentanyl concentrations during high- and very high-dose fentanyl anesthesia for coronary artery surgery
96. 2+-transients and intracellular pH in cultured cardiac myocytes
97. Effects of alfentanil on isolated cardiac tissues of the rabbit
98. Inotropic effect of meperidine: Influence of receptor and ion channel blockers in the rat atrium
99. Effects of morphine on ventricular function and myocardial contractile force
100. Contractile responses to morphine, piritramide, meperidine, and fentanyl
101. Contractile responses to morphine, piritramide, meperidine and fentanyl, A comparative study of effects on the isolated ventricular myocardium
102. Comparative cardiac contractile actions of six narcotic analgesics: Morphine, meperidine, pentazocine, fentanyl, methadone and 1-alpha-acetylmethadol (LAAM)
103. 2 anesthesia during cardiac surgery: A comparison of cardiovascular profiles
104. Comparison of sufentanil-oxygen and fentanyl-oxygen anaesthesia for coronary artery bypass grafting
105. 2 for induction of anesthesia in patients with ischemic coronary artery disease
106. Comparative cardiac contractile actions of six narcotic analgesics: Morphine, meperidine, pentazocine, fentanyl, methadone and 1-alpha-acetylmethadol (LAAM)
107. Oxygen-fentanyl anesthesia in patients with poor left ventricular function, hemodynamics and plasma fentanyl concentrations
108. Hemodynamic changes during fentanyloxygen anesthesia for aortocoronary bypass operations
109. Cardiovascular effects of diazepamfentanyl anesthesia in patients with coronary artery disease
110. Protective effect of vagotonic action of morphine sulfate on ventricular vulnerability
111. Bradycardia and asystole following the rapid administration of sufentanil with vecuronium
112. Bradycardia following sufentanil-succinylcholine
113. Asystole after anesthesia induction with fentanyl, propofol, and succinylcholine sequence
114. Effects of anaesthetic induction on myocardial function and metabolism: A comparison of fentanyl, sufentanil and alfentanil
115. Cardiac electrophysiologic effects of fentanyl and combinations of fentanyl and neuromuscular relaxants in pentobarbital anesthetized dogs
116. Negative chronotropic actions of sufentanil and vecuronium in chronically instrumented dogs pretreated with propranolol and/or diltiazem
117. Prolongation of QT interval in association with large doses of opiates
118. Epinephrine-induced dysrhythmias: Comparison during anaesthesia with narcotics and with halogenated agents in dogs
119. Effects of isoflurane and fentanyl on ischemic myocardium in dogs: Assessment by end-systolic measurements
120. Anaesthetic modification of regional myocardial functional adjustments during myocardial ischaemia: Halothane vs fentanyl
121. Functional recovery of stunned myocardium is greater with halothane than fentanyl anaesthesia in dogs
122. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart
123. Postoperative myo-cardial ischemia: Therapeutic trials using intensive analgesia following surgery
124. Effects of anaesthetic induction on myocardial function and metabolism: A comparison of fentanyl, sufentanil and alfentanil
125. Qualitative evaluation of coronary flow during anesthetic induction using thallium-201 perfusion scans
126. Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations
127. Influence of high-dose alfentanil anaesthesia on the electroencephalogram: Correlation with plasma concentrations
128. EEG quantitation of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil
129. Electroencephalographic quantitation of opioid effect: Comparative pharmacodynamics of fentanyl and sufentanil
130. Effects of opioids on vasoresponsiveness of porcine coronary artery
131. Rate of coronary flow adaptation in response to changes in heart rate before and during anesthesia for coronary artery surgery